Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1
作者:Daniel P. Mould、Ulf Bremberg、Allan M. Jordan、Matthis Geitmann、Alba Maiques-Diaz、Alison E. McGonagle、Helen F. Small、Tim C.P. Somervaille、Donald Ogilvie
DOI:10.1016/j.bmcl.2017.05.018
日期:2017.7
A series of reversibleinhibitors of lysinespecificdemethylase1 (LSD1) with a 5-hydroxypyrazole scaffold have been developed from compound 7, which was identified from the patent literature. Surface plasmon resonance (SPR) and biochemical analysis showed it to be a reversibleLSD1inhibitor with an IC50 value of 0.23 µM. Optimisation of this compound by rational design afforded compounds with Kd
已经从化合物7开发了具有5-羟基吡唑支架的一系列赖氨酸特异性脱甲基酶1(LSD1)的可逆抑制剂,其已从专利文献中鉴定。表面等离子体共振(SPR)和生化分析表明,它是可逆的LSD1抑制剂,IC 50值为0.23 µM。通过合理设计优化该化合物,可得到K d <10 nM的化合物。在人类THP-1细胞中,发现这些化合物上调替代细胞生物标志物CD86的表达。发现化合物11p在小鼠中具有中等的口服生物利用度,表明其可用作体内工具化合物的潜力。